| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | 0 | - | - | - | - | - | - |
| Total Income - EUR | 0 | 0 | - | 0 | - | - | - | - | - | - |
| Total Expenses - EUR | 1.325 | 0 | - | 0 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -1.325 | 0 | - | 0 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -1.325 | 0 | - | 0 | - | - | - | - | - | - |
| Employees | 0 | 0 | - | 0 | - | - | - | - | - | - |
Check the financial reports for the company - Vogen Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 47.323 | 46.841 | - | 45.203 | - | - | - | - | - | - |
| Current Assets | 83.629 | 82.776 | - | 79.882 | - | - | - | - | - | - |
| Inventories | 23.550 | 23.310 | - | 22.495 | - | - | - | - | - | - |
| Receivables | 61.907 | 61.275 | - | 59.133 | - | - | - | - | - | - |
| Cash | -1.828 | -1.809 | - | -1.746 | - | - | - | - | - | - |
| Shareholders Funds | -9.734 | -9.635 | - | -9.298 | - | - | - | - | - | - |
| Social Capital | 783 | 775 | - | 748 | - | - | - | - | - | - |
| Debts | 140.686 | 139.251 | - | 134.383 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4511 - 4511" | |||||||||
| CAEN Financial Year |
4511
|
|||||||||
Comments - Vogen Pharma S.r.l.